Applied Therapeutics Inc. Contracts & Agreements

Sales Agreement, dated August 11, 2023, by and between the Company and Leerink Partners LLC (Filed With SEC on August 11, 2023)

Amendment No. 1 to Form of Common Stock Purchase Warrant (Filed With SEC on May 11, 2023)

Form of Pre-Funded Common Stock Purchase Warrant (Filed With SEC on April 27, 2023)

Registration Rights Agreement, dated April 23, 2023, by and among the Company and the Purchasers (Filed With SEC on April 24, 2023)

Securities Purchase Agreement, dated April 23, 2023, by and among the Company and the Purchasers (Filed With SEC on April 24, 2023)

Form of Pre-Funded Common Stock Purchase Warrant (Filed With SEC on April 24, 2023)

Exclusive License Agreement by and between the Registrant and Mercury Pharma Group Limited, dated January 3, 2023 (Filed With SEC on March 23, 2023)

Underwriting Agreement, dated June 22, 2022, between the Company and SVB Securities LLC (Filed With SEC on June 27, 2022)

Form of Pre-Funded Warrant to Purchase Common Stock (Filed With SEC on June 27, 2022)

Form of Common Warrant to Purchase Common Stock (Filed With SEC on June 27, 2022)

Offer Letter, by and between Steven Ortega and the Registrant, dated February 1, 2021 (Filed With SEC on March 10, 2022)

Equity Distribution Agreement, dated January 26, 2022, by and between the Company and Cowen and Company, LLC (Filed With SEC on January 26, 2022)

Underwriting Agreement, dated February 11, 2021, by and among the Company and Goldman Sachs & Co. LLC, Cowen and Company, LLC and UBS Securities LLC, as representatives of the... (Filed With SEC on February 17, 2021)

Offer Letter, dated May 20, 2020, by and between Applied Therapeutics, Inc. and Chuck Silberstein (Filed With SEC on May 26, 2020)

Offer Letter, by and between the Company and Chids Mahadevan, dated December 2, 2019 (Filed With SEC on April 1, 2020)

Amendment to Employment Agreement, by and between the Registrant and Riccardo Perfetti, dated March 9, 2020 (Filed With SEC on March 13, 2020)

Employment Agreement, by and between the Registrant and Shoshana Shendelman, dated March 9, 2020 (Filed With SEC on March 13, 2020)

Description of securities registered under Section 12 of the Exchange Act (Filed With SEC on March 13, 2020)

Form of Underwriting Agreement (Filed With SEC on January 21, 2020)

Registration Rights Agreement, dated November 7, 2019, by and among the Company and the Purchasers (Filed With SEC on November 12, 2019)

Securities Purchase Agreement, dated November 7, 2019, by and among the Company and the Purchasers (Filed With SEC on November 12, 2019)

Employment Agreement, dated August 29, 2019, between Applied Therapeutics, Inc. and Mark Vignola (Filed With SEC on September 4, 2019)

Employment Agreement, dated August 28, 2019, between Applied Therapeutics, Inc. and Riccardo Perfetti (Filed With SEC on September 4, 2019)

Separation Agreement, by and between the Company and Les Funtleyder, dated May 28, 2019 (Filed With SEC on August 12, 2019)

Form of Underwriting Agreement (Filed With SEC on April 29, 2019)

2019 Equity Incentive Plan (Filed With SEC on April 29, 2019)

Forms of Option Grant Notice and Option Agreement under 2019 Equity Incentive Plan (Filed With SEC on April 29, 2019)

Form of Restricted Stock Unit Grant Notice and Unit Award Agreement under 2019 Equity Incentive Plan (Filed With SEC on April 29, 2019)

2016 Equity Incentive Plan, as amended (Filed With SEC on April 29, 2019)

2019 Employee Stock Purchase Plan (Filed With SEC on April 29, 2019)

Offer Letter between the Registrant and Mark J. Vignola, dated April 16, 2019 (Filed With SEC on April 29, 2019)

Form of Common Stock Certificate (Filed With SEC on April 24, 2019)

Form of Indemnity Agreement by and between the Registrant and its directors and executive officers (Filed With SEC on April 24, 2019)

Form of Warrant, issued to affiliates of Brookline Capital Markets, a division of CIM Securities, LLC, on March 13, 2017 (Filed With SEC on April 12, 2019)

Form of Warrant, issued to affiliates of Brookline Capital Markets, a division of CIM Securities, LLC, on November 5, 2018 (Filed With SEC on April 12, 2019)

Form of Warrant, issued to affiliates of Brookline Capital Markets, a division of CIM Securities, LLC, on April 9, 2019 (Filed With SEC on April 12, 2019)

Amended and Restated 2016 Equity Incentive Plan (Filed With SEC on April 12, 2019)

Forms of Stock Option Agreement under the Amended and Restated 2016 Equity Incentive Plan (Filed With SEC on April 12, 2019)

Offer Letter between the Registrant and Les Funtleyder, dated December 26, 2018 (Filed With SEC on April 12, 2019)

Amended and Restated Investors' Rights Agreement, by and among the Registrant and certain of its stockholders, dated November 5, 2018 (Filed With SEC on April 12, 2019)

Offer Letter between the Registrant and Riccardo Perfetti, M.D., Ph.D., effective August 27, 2018 (Filed With SEC on April 12, 2019)

Exclusive License Agreement by and between the Registrant and The Trustees of Columbia University in the City of New York, dated October 26, 2016 (Filed With SEC on April 12, 2019)